2025
SJR Q1
JCR Q1 · 56,1
17 matched articles
SCIE
Journal detail
Cancer Cell
- Publisher
- Cell Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1535610818783686
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 26,632
- Quartile Q1
- H-Index 436
- Cites/doc 34,25
- Docs (3y) 556
- Cites (3y) 17.747
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 56,1
- 5Y JIF 58,5
- JCI 8,22
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Cell Biology Q1
- Oncology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology | Cell Biology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 26,632 | 56,1 | 58,5 | 8,22 | Q1 | 436 |
| 2024 | Q1 | Q1 | 19,027 | 44,5 | 47,2 | 8,07 | Q1 | 416 |
| 2023 | Q1 | Q1 | 17,507 | 48,8 | 42,1 | 7,57 | Q1 | 416 |
| 2022 | Q1 | Q1 | 12,578 | 50,3 | 43,9 | 6,44 | Q1 | 416 |
| 2021 | Q1 | Q1 | 9,975 | 38,6 | 41,2 | 5,12 | Q1 | 416 |
| 2020 | Q1 | Q1 | 13,035 | 31,7 | 35,5 | 5,31 | Q1 | 416 |
| 2019 | Q1 | Q1 | 11,909 | 26,6 | 30,2 | 5,25 | Q1 | 416 |
| 2018 | — | Q1 | — | 23,9 | 26,8 | 5,2 | Q1 | — |
| 2017 | Q1 | Q1 | 12,7 | 22,8 | 27,1 | 5,41 | Q1 | 416 |
| 2016 | Q1 | Q1 | 13,509 | 27,4 | 27,7 | — | — | 416 |
| 2015 | Q1 | Q1 | 13,74 | 23,2 | 26,3 | — | — | 416 |
| 2014 | Q1 | Q1 | 14,883 | 23,5 | 27,3 | — | — | 416 |
| 2013 | Q1 | Q1 | 17,638 | 23,9 | 27,2 | — | — | 416 |
| 2012 | Q1 | Q1 | 16,267 | 24,8 | 27,1 | — | — | 416 |
| 2011 | Q1 | Q1 | 16,203 | 26,6 | 28,2 | — | — | 416 |
| 2010 | Q1 | Q1 | 16,468 | 26,9 | 28,4 | — | — | 416 |
| 2009 | — | Q1 | — | 25,3 | 26,6 | — | — | — |
| 2008 | — | Q1 | — | 25 | 23,3 | — | — | — |
| 2007 | — | Q1 | — | 23,9 | 22 | — | — | — |
| 2006 | — | Q1 | — | 24,1 | — | — | — | — |
| 2005 | — | Q1 | — | 18,7 | — | — | — | — |
| 2004 | — | Q1 | — | 18,1 | — | — | — | — |
| 2003 | — | Q1 | — | 18,9 | — | — | — | — |
| 2002 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q1 | Q1 | 3/207 |
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 5/333 |
| 2024 | CELL BIOLOGY | SCIE | Q1 | Q1 | 4/204 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 5/328 |
| 2023 | CELL BIOLOGY | SCIE | Q1 | Q1 | 3/205 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 5/322 |
| 2022 | CELL BIOLOGY | SCIE | Q1 | Q1 | 4/191 |
| 2022 | ONCOLOGY | SCIE | Q1 | Q1 | 6/241 |
| 2021 | CELL BIOLOGY | SCIE | Q1 | Q1 | 5/195 |
| 2021 | ONCOLOGY | SCIE | Q1 | Q1 | 8/245 |
| 2020 | CELL BIOLOGY | SCIE | Q1 | Q1 | 4/195 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 9/242 |
| 2019 | CELL BIOLOGY | SCIE | Q1 | Q1 | 4/195 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 7/244 |
| 2018 | CELL BIOLOGY | SCIE | Q1 | Q1 | 4/193 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 7/230 |
| 2017 | CELL BIOLOGY | SCIE | Q1 | Q1 | 5/190 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 7/223 |
| 2016 | CELL BIOLOGY | SCIE | Q1 | — | 4/190 |
| 2016 | ONCOLOGY | SCIE | Q1 | — | 4/217 |
| 2015 | CELL BIOLOGY | SCIE | Q1 | — | 4/187 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 4/213 |
| 2014 | CELL BIOLOGY | SCIE | Q1 | — | 4/184 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 4/211 |
| 2013 | CELL BIOLOGY | SCIE | Q1 | — | 4/185 |
| 2013 | ONCOLOGY | SCIE | Q1 | — | 4/203 |
| 2012 | CELL BIOLOGY | SCIE | Q1 | — | 4/185 |
| 2012 | ONCOLOGY | SCIE | Q1 | — | 4/197 |
| 2011 | CELL BIOLOGY | SCIE | Q1 | — | 3/181 |
| 2011 | ONCOLOGY | SCIE | Q1 | — | 3/196 |
| 2010 | CELL BIOLOGY | SCIE | Q1 | — | 3/178 |
| 2010 | ONCOLOGY | SCIE | Q1 | — | 3/185 |
| 2009 | ONCOLOGY | SCIE | Q1 | — | 3/166 |
| 2008 | ONCOLOGY | SCIE | Q1 | — | 3/143 |
| 2007 | ONCOLOGY | SCIE | Q1 | — | 3/132 |
| 2006 | ONCOLOGY | SCIE | Q1 | — | 3/127 |
| 2005 | ONCOLOGY | SCIE | Q1 | — | 3/123 |
| 2004 | ONCOLOGY | SCIE | Q1 | — | 3/123 |
| 2003 | ONCOLOGY | SCIE | Q1 | — | 3/120 |
| 2002 | ONCOLOGY | SCIE | — | — | — |